🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Uveal Melanoma

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma NCT06581406Phase 2, Phase 333 sites📍 Scottsdale📍 La Jolla📍 Los Angeles Replimune, Inc. · Tests: RP2, Ipilimumab, Nivolumab Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma NCT07136181Phase 1, Phase 23 sites📍 Scottsdale📍 Denver📍 Nashville Novelwise Pharmaceutical Corporation · Tests: NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of… A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. NCT06022029Phase 116 sites📍 Los Angeles📍 Tamarac📍 Canton OncoNano Medicine, Inc. · Tests: ONM-501, Cemiplimab Adjuvant Melatonin for Uveal Melanoma NCT05502900Phase 31 site📍 Stockholm Gustav Stalhammar · Tests: Melatonin A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma NCT05607095Phase 12 sites📍 Harrison📍 New York Memorial Sloan Kettering Cancer Center · Tests: Lifileucel (LN-144/LN-145) Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma NCT07501117Phase 11 site📍 Herlev Inge Marie Svane · Tests: Nivolumab & Ipilimumab ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors NCT03686124Phase 1, Phase 221 sites📍 Stanford📍 Aurora📍 Miami Immatics US, Inc. · Tests: IMA203 Product, IMA203 product- flat dose, IMA203CD8 Product, Nivolumab, IMADetect® Neoadjuvant Tebentafusp for Uveal Melanoma NCT06414590Phase 22 sites📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Tebentafusp-Tebn Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver NCT07364474NA1 site📍 Boston Massachusetts General Hospital · Tests: Melphalan through Percutaneous Hepatic Perfusion, Melphalan through Percutaneous Hepatic Perfusion in combination with … Observational Study of Iris Tumors NCT03809585n/a1 site📍 Portland Oregon Health and Science University Adjuvant Tebentafusp in High Risk Ocular Melanoma NCT06246149Phase 315 sites📍 Lake Success📍 Brussels📍 Nice European Organisation for Research and Treatment of Cancer … · Tests: Tebentafusp MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer NCT04729543Phase 1, Phase 21 site📍 Rotterdam Erasmus Medical Center · Tests: Adoptive therapy with autologous MC2 TCR T cells Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma NCT07804186Phase 313 sites📍 Scottsdale📍 Los Angeles📍 Boston IDEAYA Biosciences · Tests: Darovasertib, Crizotinib (Xalkori) Neoadjuvant Darovasertib in Primary Uveal Melanoma NCT07015190Phase 394 sites📍 Scottsdale📍 La Jolla📍 Los Angeles IDEAYA Biosciences · Tests: Darovasertib, Primary Local Therapy Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis NCT07203391Phase 12 sites📍 Sydney📍 Melbourne St Vincent's Hospital, Sydney · Tests: roginolisib Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome NCT04792463n/a1 site📍 Columbus Mohamed Abdel-Rahman Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma NCT06550674NA1 site📍 Clermont-Ferrand Centre Jean Perrin · Tests: Constitutional exome analysis Resistance Exercise in Patients With Ocular Melanoma NCT06970236NA1 site📍 Valencia University of Valencia · Tests: Exercise A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit NCT06805825Phase 15 sites📍 Ann Arbor📍 Cleveland📍 Portland Novelty Nobility, Inc. · Tests: NN3201 A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body NCT06413680Phase 1, Phase 211 sites📍 Los Angeles📍 San Francisco📍 North Haven Regeneron Pharmaceuticals · Tests: REGN10597, Cemiplimab Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma NCT06121180Phase 24 sites📍 Los Angeles📍 Tampa📍 Chicago H. Lee Moffitt Cancer Center and Research Institute · Tests: ZIV-Aflibercept, Cemiplimab Adding IL-2 to Tebentafusp to Eradicate Cancer Progression NCT07063875Phase 1, Phase 22 sites📍 Sydney📍 Melbourne St Vincent's Hospital, Sydney · Tests: Aldesleukin Retrospective Register for Uveal Melanoma NCT05733728n/a1 site📍 Vienna Medical University of Vienna · Tests: any therapy suitable Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites📍 Duarte📍 Los Angeles📍 Stanford Anusha Kalbasi · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) NCT04424719NA1 site📍 Paris Institut Curie · Tests: Blood test Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma NCT01438658n/a1 site📍 Jerusalem Hadassah Medical Organization A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel NCT06940739Phase 1, Phase 25 sites📍 Denver📍 Chapel Hill📍 Nashville Iovance Biotherapeutics, Inc. · Tests: IOV-3001 Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours NCT04855435Phase 15 sites📍 Herlev📍 Barcelona📍 Madrid MonTa Biosciences ApS · Tests: MBS8(1V270), MBS8(1V270) and pembrolizumab combination Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions NCT03947385Phase 1, Phase 215 sites📍 Los Angeles📍 San Francisco📍 Denver IDEAYA Biosciences · Tests: IDE196, Binimetinib, Crizotinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy